Compass Therapeutics to be added to Russell 2000, 3000 Indexes June 26

Compass Therapeutics announced that it will be added to the Russell 2000 and Russell 3000. Indexes as part of the Russell indexes annual reconstitution, effective after the US market opens on June 26. “We are pleased to be added to the Russell Indexes,” said Vered Bisker-Leib, President & COO of Compass Therapeutics. “The inclusion of Compass will enhance trading activity of our stock and broaden our exposure to the investment community, which may help accelerate our efforts to develop next generation antibodies into transformative cancer therapies that improve patients’ lives.”